Last reviewed · How we verify
Bromosulphalein (sulfobromophthalein)
Bromosulphalein (generic name: sulfobromophthalein) is a sulfobromophthalein drug. It is currently in unknown development for Diagnostic aid.
Bromosulphalein works by binding to and inhibiting the enzyme hematopoietic prostaglandin D synthase.
Bromosulphalein is a small molecule used in liver function tests, where its rate of removal from the bloodstream is measured to assess liver function. The liver detoxifies bromosulphalein by attaching it to glutathione, the body's master antioxidant.
At a glance
| Generic name | sulfobromophthalein |
|---|---|
| Drug class | sulfobromophthalein |
| Target | Hematopoietic prostaglandin D synthase |
| Therapeutic area | Hematology |
| Phase | unknown |
Mechanism of action
Think of it like a key fitting into a lock. Bromosulphalein is the key that fits into the lock of the enzyme, preventing it from working properly. This helps doctors understand how well the liver is functioning.
Approved indications
- Diagnostic aid
Common side effects
Key clinical trials
- Tele-CBT Following Bariatric Surgery: Randomized Control Trial (NA)
- The Role of the Upper Colliculus in the Idiopathic Blepharospasm (NA)
- Screening of OSA in Hospitalized Stroke Patients Using BSP (NA)
- Optimizing a Drug Abuse Prevention Program for Dissemination (NA)
- Psychotherapy for Depressed Mothers of Psychiatrically Ill Children (NA)
- Interpersonal Therapy for Depression in Breast Cancer (PHASE4)
- Brain Stimulation to Treat Blepharospasm or Meige Syndrome (PHASE2)
- Effect of Buscopan on Gastrointestinal Imaging Quality With Probe-based Confocal Laser Endomicroscopy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Bromosulphalein CI brief — competitive landscape report
- Bromosulphalein updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Bromosulphalein
What is Bromosulphalein?
How does Bromosulphalein work?
What is Bromosulphalein used for?
What is the generic name of Bromosulphalein?
What drug class is Bromosulphalein in?
What development phase is Bromosulphalein in?
What does Bromosulphalein target?
Related
- Drug class: All sulfobromophthalein drugs
- Target: All drugs targeting Hematopoietic prostaglandin D synthase
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Hematology
- Indication: Drugs for Diagnostic aid
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing